{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:38:51Z","timestamp":1758040731003,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,11]]},"DOI":"10.7759\/cureus.92037","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:49:39Z","timestamp":1757584179000},"source":"Crossref","is-referenced-by-count":0,"title":["Long-Term Peritoneal Dialysis in Hereditary Transthyretin Amyloidosis: A Case Report and Management Challenges"],"prefix":"10.7759","author":[{"given":"V\u00edtor","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Paulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Beco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Pestana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-024-00399-3","article-title":"Uncovering the knowledge about systemic amyloidosis relevant to the rheumatologists","volume":"64","author":"Pereira IA","year":"2024","unstructured":"Pereira IA, Neto NS, do Nascimento RR, et al.. Uncovering the knowledge about systemic amyloidosis relevant to the rheumatologists. Adv Rheumatol. 2024, 64:71. 10.1186\/s42358-024-00399-3","journal-title":"Adv Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2024.2405948","article-title":"Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"31","author":"Buxbaum JN","year":"2024","unstructured":"Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, et al.. Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2024, 31:249-56. 10.1080\/13506129.2024.2405948","journal-title":"Amyloid"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"Muchtar E","year":"2021","unstructured":"Muchtar E, Dispenzieri A, Magen H, et al.. Systemic amyloidosis from A (AA) to T (ATTR): a review. J Intern Med. 2021, 289:268-92. 10.1111\/joim.13169","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.01.530","article-title":"2024 update on classification, etiology, and typing of renal amyloidosis: a review","volume":"84","author":"Leung N","year":"2024","unstructured":"Leung N, Nasr SH. 2024 update on classification, etiology, and typing of renal amyloidosis: a review. Am J Kidney Dis. 2024, 84:361-73. 10.1053\/j.ajkd.2024.01.530","journal-title":"Am J Kidney Dis"},{"key":"ref5","article-title":"Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M)","volume":"16","author":"Lobato L","year":"2003","unstructured":"Lobato L. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M). J Nephrol. 2003, 16:438-42.","journal-title":"J Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08720811","article-title":"Transthyretin amyloidosis and the kidney","volume":"7","author":"Lobato L","year":"2012","unstructured":"Lobato L, Rocha A. Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol. 2012, 7:1337-46. 10.2215\/CJN.08720811","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","article-title":"Afectaci\u00f3n renal en la amiloidosis. Caracter\u00edsticas cl\u00ednicas, evoluci\u00f3n y supervivencia [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival]","volume":"26","author":"Esteve V","year":"2006","unstructured":"Esteve V, Almirall J, Ponz E, et al.. Afectaci\u00f3n renal en la amiloidosis. Caracter\u00edsticas cl\u00ednicas, evoluci\u00f3n y supervivencia [Renal involvement in amyloidosis. Clinical outcomes, evolution and survival]. Nefrologia. 2006, 26:212-7.","journal-title":"Nefrologia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/13506120410001673884","article-title":"End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors","volume":"11","author":"Lobato L","year":"2004","unstructured":"Lobato L, Beir\u00e3o I, Silva M, et al.. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid. 2004, 11:27-37. 10.1080\/13506120410001673884","journal-title":"Amyloid"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/014107688407700306","article-title":"Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease","volume":"77","author":"Browning MJ","year":"1984","unstructured":"Browning MJ, Banks RA, Harrison P, Tribe CR, Fraley CT, Zachary G, Mackenzie C. Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease. J R Soc Med. 1984, 77:189-92. 10.1177\/014107688407700306","journal-title":"J R Soc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.26444\/jpccr\/75444","article-title":"Long-time survival of a female with primary amyloidosis treated by peritoneal dialysis","volume":"11","author":"Grzebalska A","year":"2017","unstructured":"Grzebalska A, Sak J, Prystupa A, Ksi\u0105\u017cek A. Long-time survival of a female with primary amyloidosis treated by peritoneal dialysis. J Pre Clin Clin Res. 2017, 11:22-4. 10.26444\/jpccr\/75444","journal-title":"J Pre Clin Clin Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1193","article-title":"Peritoneal amyloid as a presenting manifestation of AL amyloid","volume":"13","author":"Acharya I","year":"2023","unstructured":"Acharya I, Dominah GA, Xing D, Allen E, Iding JS, Haas CJ. Peritoneal amyloid as a presenting manifestation of AL amyloid. J Community Hosp Intern Med Perspect. 2023, 13:96-102. 10.55729\/2000-9666.1193","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0896860820982218","article-title":"ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention","volume":"41","author":"Morelle J","year":"2021","unstructured":"Morelle J, Stachowska-Pietka J, \u00d6berg C, et al.. ISPD recommendations for the evaluation of peritoneal membrane dysfunction in adults: classification, measurement, interpretation and rationale for intervention. Perit Dial Int. 2021, 41:352-72. 10.1177\/0896860820982218","journal-title":"Perit Dial Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197807000-00008","article-title":"Chronic peritoneal dialysis in a patient with primary amyloidosis, renal failure, and factor X deficiency","volume":"71","author":"Stone WJ","year":"1978","unstructured":"Stone WJ, Latos DL, Lankford PG, Baker AS. Chronic peritoneal dialysis in a patient with primary amyloidosis, renal failure, and factor X deficiency. South Med J. 1978, 71:764-7. 10.1097\/00007611-197807000-00008","journal-title":"South Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae233","article-title":"Experience with tafamidis in peritoneal dialysis for a patient diagnosed with transthyretin cardiac amyloidosis","volume":"17","author":"Fazlic DL","year":"2024","unstructured":"Fazlic DL, Garc\u00eda SA, Gerard M, et al.. Experience with tafamidis in peritoneal dialysis for a patient diagnosed with transthyretin cardiac amyloidosis. Clin Kidney J. 2024, 17:sfae233. 10.1093\/ckj\/sfae233","journal-title":"Clin Kidney J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390545-long-term-peritoneal-dialysis-in-hereditary-transthyretin-amyloidosis-a-case-report-and-management-challenges","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:49:40Z","timestamp":1757584180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390545-long-term-peritoneal-dialysis-in-hereditary-transthyretin-amyloidosis-a-case-report-and-management-challenges"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.92037","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}